Search
Trelnarizine
go.drugbank.com/drugs/DB21183ExperimentalTrelnarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Trelnarizine is a antihistaminic/cerebral (or peripheral) vasodilator.
Emorfazone
go.drugbank.com/drugs/DB21286ExperimentalEmorfazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Emorfazone is a anti-inflammatory analgesic, phenylbutazone derivative.
Fibracillin
go.drugbank.com/drugs/DB21302ExperimentalFibracillin is a small molecule drug. The usage of the INN stem '-cillin' in the name indicates that Fibracillin is a antibiotic, 6-aminopenicillanic acid derivative.
Ipazilide
go.drugbank.com/drugs/DB21330ExperimentalIpazilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ipazilide is a sematilide derivative class III antiarrhythmic.
Pidobenzone
go.drugbank.com/drugs/DB21369ExperimentalPidobenzone is a small molecule drug. The usage of the INN stem '-zone' in the name indicates that Pidobenzone is a anti-inflammatory analgesic, phenylbutazone derivative.
Trifezolac
go.drugbank.com/drugs/DB21380ExperimentalTrifezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Trifezolac is a anti-inflammatory agent, ibufenac derivative.
Pulrodemstat
go.drugbank.com/drugs/DB21497ExperimentalPulrodemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor.
Zavolosotine
go.drugbank.com/drugs/DB21531ExperimentalZavolosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist.
Branosotine
go.drugbank.com/drugs/DB21674ExperimentalBranosotine is a small molecule drug. The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist.
Nalorphine
go.drugbank.com/drugs/DB11490ExperimentalVet approvedIt is used to reverse opioid overdose and (starting in the 1950s) in a challenge test to determine opioid dependence. … It acts at two opioid receptors—at the mu receptor it has antagonistic effects, and at the kappa receptors it exerts high-efficacy agonistic characteristics.